Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matassini

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
European Journal of Medicinal Chemistry|April 2, 2025
Acetal functionalized iminosugars for targeting β-glucocerebrosidase modulationMaria Giulia Davighi, Francesca Clemente, Camilla Matassini, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 7, 2017
Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart SurveyFederico Guerra, Michela Brambatti, Robby Nieuwlaat, et al.
Organic & Biomolecular Chemistry|February 2, 2022
Photoswitchable inhibitors of human β-glucocerebrosidaseMaria Giulia Davighi, Francesca Clemente, Camilla Matassini, et al.
International Journal of Cardiology|September 2, 2014
Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: a randomized, open-blinded, prospective studyFederico Guerra, Ilaria Pavoni, Andrea Romandini, et al.
The Journal of Organic Chemistry|September 1, 2021
Piperidine Azasugars Bearing Lipophilic Chains: Stereoselective Synthesis and Biological Activity as Inhibitors of Glucocerebrosidase (GCase)Francesca Clemente, Camilla Matassini, Sara Giachetti, et al.
European Journal of Medicinal Chemistry|June 2, 2026
Multivalent C2-alkyl trihydroxypiperidine architectures modulate β-glucocerebrosidase activityFrancesca Buco, Francesca Clemente, Francesca Cardona, et al.
Molecules (Basel, Switzerland)|July 9, 2022
Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 GangliosidosisFrancesca Clemente, Macarena Martínez-Bailén, Camilla Matassini, et al.
Bioorganic Chemistry|August 20, 2025
Studies on Azasugar-based sulfonamides: a new class of Carbonic Anhydrase inhibitorsDebora Pratesi, Francesco Brenzini Biagioni, Camilla Matassini, et al.
Aging|March 9, 2016
Exercise: a "new drug" for elderly patients with chronic heart failureRoberto Antonicelli, Liana Spazzafumo, Simonetta Scalvini, et al.
Bioorganic Chemistry|March 23, 2020
Glucocerebrosidase (GCase) activity modulation by 2-alkyl trihydroxypiperidines: Inhibition and pharmacological chaperoningF Clemente, C Matassini, C Faggi, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
European Journal of Medicinal Chemistry|April 2, 2025
Acetal functionalized iminosugars for targeting β-glucocerebrosidase modulationMaria Giulia Davighi, Francesca Clemente, Camilla Matassini, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 7, 2017
Symptomatic atrial fibrillation and risk of cardiovascular events: data from the Euro Heart SurveyFederico Guerra, Michela Brambatti, Robby Nieuwlaat, et al.
Organic & Biomolecular Chemistry|February 2, 2022
Photoswitchable inhibitors of human β-glucocerebrosidaseMaria Giulia Davighi, Francesca Clemente, Camilla Matassini, et al.
International Journal of Cardiology|September 2, 2014
Feasibility of a cardiologist-only approach to sedation for electrical cardioversion of atrial fibrillation: a randomized, open-blinded, prospective studyFederico Guerra, Ilaria Pavoni, Andrea Romandini, et al.
The Journal of Organic Chemistry|September 1, 2021
Piperidine Azasugars Bearing Lipophilic Chains: Stereoselective Synthesis and Biological Activity as Inhibitors of Glucocerebrosidase (GCase)Francesca Clemente, Camilla Matassini, Sara Giachetti, et al.
European Journal of Medicinal Chemistry|June 2, 2026
Multivalent C2-alkyl trihydroxypiperidine architectures modulate β-glucocerebrosidase activityFrancesca Buco, Francesca Clemente, Francesca Cardona, et al.
Molecules (Basel, Switzerland)|July 9, 2022
Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 GangliosidosisFrancesca Clemente, Macarena Martínez-Bailén, Camilla Matassini, et al.
Bioorganic Chemistry|August 20, 2025
Studies on Azasugar-based sulfonamides: a new class of Carbonic Anhydrase inhibitorsDebora Pratesi, Francesco Brenzini Biagioni, Camilla Matassini, et al.
Aging|March 9, 2016
Exercise: a "new drug" for elderly patients with chronic heart failureRoberto Antonicelli, Liana Spazzafumo, Simonetta Scalvini, et al.
Bioorganic Chemistry|March 23, 2020
Glucocerebrosidase (GCase) activity modulation by 2-alkyl trihydroxypiperidines: Inhibition and pharmacological chaperoningF Clemente, C Matassini, C Faggi, et al.
Pageof 10